John Choe Appointed Western Sales Director at Buzz Bomb Caffeine Company

Aspire Biopharma’s subsidiary, Buzz Bomb Caffeine Company, has announced the appointment of John Choe as its Western Sales Director. The company confirmed the decision on March 17, 2026. This move is part of Buzz Bomb’s efforts to strengthen its sales operations in the western region and expand its market presence.

John Choe brings extensive experience in sales leadership to his new role. His appointment aligns with Buzz Bomb Caffeine Company’s strategic goals to enhance regional outreach and drive growth within the western territories. Aspire Biopharma continues to focus on leveraging its subsidiaries to bolster overall performance and market competitiveness.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: March 17, 2026

Author

GOAI